442562-86-9 Usage
Uses
Used in Pharmaceutical Research and Development:
[3-(1H-indol-4-yl)-phenyl]-acetic acid methyl ester is utilized as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure and functional groups contribute to the development of molecules with potential therapeutic applications, making it an essential component in the design and creation of novel drugs.
Used in Drug Discovery:
As a member of the indole class of organic compounds, [3-(1H-indol-4-yl)-phenyl]-acetic acid methyl ester is employed as a starting material for the discovery of new drugs. Its biological activity and structural features allow researchers to explore its potential in treating various diseases and conditions, thus expanding the scope of available pharmaceutical options.
Used in Medicinal Chemistry:
[3-(1H-indol-4-yl)-phenyl]-acetic acid methyl ester serves as a valuable building block in medicinal chemistry, where it is used to construct complex molecular structures with specific pharmacological properties. Its presence in the indole class of compounds further enhances its utility in the development of targeted therapies and innovative treatments for a wide range of medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 442562-86-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,2,5,6 and 2 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 442562-86:
(8*4)+(7*4)+(6*2)+(5*5)+(4*6)+(3*2)+(2*8)+(1*6)=149
149 % 10 = 9
So 442562-86-9 is a valid CAS Registry Number.
442562-86-9Relevant academic research and scientific papers
4-aryl substituted indolinones
-
, (2008/06/13)
The present invention relates to 4-arylindolinones, as well as pharmaceutical compositions thereof, capable of modulating protein kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation. The present invention also relates to methods for treating protein kinase related disorders.
